Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors

This study has been completed.
Information provided by:
National Institutes of Health Clinical Center (CC) Identifier:
First received: December 1, 2010
Last updated: August 6, 2016
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Estimated Primary Completion Date: No date given